Results 71 to 80 of about 8,118 (161)

High-dose, short-course primaquine after point-of-care G6PD testing for the radical cure of <i>Plasmodium vivax</i> malaria: a safety study in Papua New Guinea and Indonesia. [PDF]

Lancet Reg Health West Pac
Fransisca L, Ome-Kaius M, Laman M, Poespoprodjo JR, Pasaribu AP, Sutanto I, Malai M, Nelwan E, Adella J, Abegini C, Ainur F, Amdara Y, Angeline S, Brown K, Burdam FH, Curry E, Daimen M, Daly P, Do T, Dori A, Douglas NM, Huegel H, Hutagalung AP, Jambert E, Jimanto V, Karo V, Kenangalem E, Kelebi T, Kisomb J, Laksono I, Lee G, Ley B, Mannion K, Plinduo J, Pukai I, Putri A, Rajasekhar M, Ronkentou S, Rosens E, Sakalidis VS, Satyagraha A, Simpson JA, Theodora M, Ubra R, Vakore N, Wansom T, Duparc S, Robinson LJ, Price RN.   +48 more
europepmc   +1 more source

Dissemination of EFFORT trial results in Indonesia: a stakeholder meeting report on tafenoquine and primaquine for radical cure of Plasmodium vivax. [PDF]

Malar J
Pasaribu AP, Jimanto V, Ainur F, Saragih NR, Hadi H, Siagian DSP, Sinaga BJ, Satyagraha AW, Laihad FJ, Diptyanusa A, Ubra RR, Tekege O, Darmayanti L, Herdiana H, Adella J, Mannion K, Curry E, Poespoprodjo JR, Kenangalem E, Burdam FH, Sutanto I, Nelwan EJ, Ganadhi GJ, Shrestha B, Mnjala H, Hawley WA, Prameswari HD, Theodora M, Silalahi FSM, Susanto H, Immanuella F, Puspadewi RT, Fajariyani SB, Samad I, Supriyanto D, Muhafilah N, Isa R, Price RN, Thriemer K.   +38 more
europepmc   +1 more source

Epidemiological patterns and healthcare utilization among malaria patients in Sorong City, Papua, Indonesia: A cross-sectional analysis of national surveillance data. [PDF]

PLoS One
Susilawati TN, Susanto H, Pham OKN, Kondororik F, Dewi VNL, Ahmar H, Putri NR, Lee R, Duong MC.   +8 more
europepmc   +1 more source

An Increase in Imported <i>Plasmodium vivax</i> Malaria in New York City: Clinical and Demographic Trends Following Recent Migration. [PDF]

Open Forum Infect Dis
Berto CG, Policarpio MA, Vargas-Pena C, Antwi M, Slavinski S, Abdool A, King RN, Kojaoghlanian T, Daily JP, Prasad N, Velasquez MR, Ridpath AD, Coyle CM.   +12 more
europepmc   +1 more source

Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial. [PDF]

Lancet Infect Dis
Degaga TS, Pasaribu AP, Tripura R, Ghanchi N, Rajasekhar M, Adhikari B, Ley B, Bamboro SA, Jabbar FA, Hasibuan N, Tego TT, Zehra S, Qurashi B, Mnjala H, Lee G, Li P, Kazi AM, Safitri W, Yulita Y, Siagian DSP, Syahputra D, Hadi H, Muhammad T, Ibrahim A, Syed N, Dost K, Puspitrasari AM, Kariodimedjo PP, Rai A, Rumaseb A, Sutanto E, Ean M, Khan A, Sokha M, Commons RJ, Weston S, Noviyanti R, Peto T, Callery JJ, Ali U, Mehmood T, Dondorp A, Devine A, Setiawan E, Mwaura M, Cassidy-Seyoum S, Temesgen R, Abate DT, Erjabo EB, Gessa GG, Kiros FG, Usmani MI, Raza A, Woyessa A, Hailu A, Simpson JA, Karahalios A, Beg MA, von Seidlein L, Dysoley L, Auburn S, Price RN, Thriemer K.   +62 more
europepmc   +1 more source

Efficacy of artemether lumefantrine vs chloroquine for the treatment of Plasmodium Vivax infection in Pakistan. [PDF]

Sci Rep
Khan S, Muqtadir J, Abbas SA, Ayoob K, Wahab A, Zaidi SHM, Das B, Bhatti S, Vohra EA.   +8 more
europepmc   +1 more source

Clinical perspectives on hemoglobin measurement: The example of malaria radical cure. [PDF]

PLOS Glob Public Health
Chu CS, Brindle E, Degaga TS, Duparc S, Gerth-Guyette E, Hsiang M, Lacerda M, Thriemer K, Noviyanti R, Pereira D, Price R, Robinson LJ, Vidal-Cardenas E, Yilma D, Domingo GJ, Zobrist S.   +15 more
europepmc   +1 more source

Differential impact of Tafenoquine and Primaquine on <i>Plasmodium vivax</i> recurrence: the role of <i>CYP2D6</i> variants. [PDF]

Antimicrob Agents Chemother
Godinho VKC, Mwangi VI, Morais MC, Lopes APB, Alves JRdS, Brito MAM, Lacerda MVGd, Trindade Maranhão Costa F, Almeida ACGd, Melo GCd.   +9 more
europepmc   +1 more source

Moving towards high-dose primaquine or single-dose tafenoquine for Plasmodium vivax treatment in Cambodia: a meeting report from dissemination of results of the EFFORT trial to stakeholders. [PDF]

Malar J
Dysoley L, Cassidy-Seyoum S, Adhikari B, Dahal A, Phoumen N, Srey S, Phalla T, Vonn P, Engrkruy B, Sovanarath O, Mengkea H, Rathana P, Makara I, Heng PK, Heng Y, Khlok H, Pong K, Moeng T, Vantha S, Soviet U, Ravuth R, Bunreth V, Vannak K, Sokhann M, Kimmen K, Dy K, Samol S, Lo K, Sokunthea N, Kry H, Kanha L, Naren L, Oum S, Sovann Y, Channavuth R, Bunmeng C, Hughes J, Brindle H, Hu Y, Peng S, Mardi P, Chanry I, Preap S, Heoy S, Sabawoon F, Sokha T, Ringwald P, Lynch CA, Price RN, Tripura R, von Seidlein L, Devine A, Thriemer K.   +52 more
europepmc   +1 more source

Cerebral malaria caused by Plasmodium vivax in an afrodescendant adult in Colombia: case report. [PDF]

Malar J
Sastre-Martínez AD, Gutiérrez MAG, Vallejo-Serna RA, Muñoz-Lombo JP.   +3 more
europepmc   +1 more source